ARTICLE | Company News
Array BioPharma, Signal Genetics deal
October 4, 2010 7:00 AM UTC
Array will use Signal Genetics' MyPRS genomic testing technology in two upcoming clinical trials of ARRY-520. Array expects to start two Phase II trials of the small molecule kinesin spindle protein...